Cerulean Pharma Inc. is a privately-held biopharmaceutical company focused on the development of novel nanotechnology-based therapeutics in the areas of oncology, cardiovascular, autoimmune and inflammatory diseases.
The Company has assembled a world-class management team, board of directors and scientific advisory board that collectively have a significant track record of business building, product development and scientific breakthroughs from companies and institutions such as Cubist, GlaxoSmithKline, Merck, Millennium Pharmaceuticals, Inc., Pfizer, Wyeth, the Massachusetts Institute of Technology, Harvard Medical School, MD Anderson, Fox Chase Cancer Center and the Arizona Health Center.
Current Team (8)Update
Senior Vice President and Chief Business Officer
Vice President, Research
President and Chief Executive Officer
Senior Vice President, Finance and Administration
Co-Founder and Board of Directors
Senior Vice President, General Counsel
Vice President, Pharmaceutical Sciences and Manufacturing
Funding Rounds (9) - $90.7MUpdate
$13M / Private Equity
Dec 14, 2012
$15M / Series D
Dec 15, 2011Investors:
$24M / Series C
Nov 15, 2010Investors:
$1.5M / Undisclosed
Oct 14, 2010
$5M / Debt Financing
Jun 10, 2010
$10M / Series B
Jul 28, 2009Investors:
$8.1M / Series B
Jan 3, 2008Investors:
$12.1M / Series A
May 23, 2007Investors:
$2M / Undisclosed
Dec 1, 2006Investors:
Board Members and Advisors (5)Update
Polaris Partners is a venture company investing in digital media, life sciences, and enterprise...
Venrock is a venture capital firm investing in technology and healthcare companies.
Emerging Technology VC
Bessemer Venture Partners has over 100 years of investing experience, with a portfolio ranging...
Alexandria Real Estate Equities, Inc., Landlord of Choice to the Life Science Industry, is the...
161 First Street
Cambridge, MA 02142